Could a party drug ease long COVID's debilitating symptoms?
NCT ID NCT06821087
Summary
This small pilot study is exploring whether ketamine, a medication used for anesthesia and depression, can help relieve the persistent fatigue and cognitive problems ('brain fog') experienced by people with Long COVID. Twenty adults will receive four ketamine injections over two weeks, with researchers measuring changes in their symptoms, brain function via MRI, and blood markers. The goal is to see if this approach is safe and shows enough promise to warrant larger studies for a condition with very few treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UT Health Austin
Austin, Texas, 78712, United States
Conditions
Explore the condition pages connected to this study.